Heron Therapeutics | Creditori Commerciali

Prezzo Delle Azioni
1.30
Cambio Giornaliero
0.02 1.17%
Mensile
-13.09%
Annuale
-21.99%
Q1 Previsione
2.71




Creditori Commerciali Cambiamento Data
ALKERMES USD 68M 31.21M 2025-09
Alnylam Pharmaceuticals USD 117.59M 15.2M 2025-09
Amarin USD 36.71M 8M 2025-09
ANI Pharmaceuticals USD 69.8M 15.23M 2025-09
Anika Therapeutics USD 4.73M 39K 2025-09
Arrowhead Research USD 32.94M 15.26M 2025-12
Eisai JPY 85.49B 4.76B 2025-12
Esperion Therapeutics USD 77.51M 2.81M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Heron Therapeutics USD 12.02M 20K 2025-09
Insmed USD 79.59M 1.24M 2025-09
Ligand Pharmaceuticals USD 27.76M 1.72M 2025-09
Merck USD 4.15B 102M 2025-09
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Neurocrine Biosciences USD 119.9M 15.3M 2025-09
Omeros USD 8.84M 4.42M 2025-06
Pacira USD 17.69M 12.44M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Surmodics USD 2.79M 400K 2024-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Veracyte USD 5.51M 5.94M 2025-09
Vertex Pharmaceuticals USD 4.03B 320.8M 2025-09


Heron Therapeutics Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.